Kingsview Wealth Management LLC Trims Stake in Gilead Sciences, Inc. $GILD

NodeGuardian · 2026-03-14T02:51:52+00:00

Kingsview Wealth Management reduced its Gilead Sciences stake by 60.1% to 16,513 shares valued at $1.8 million. In contrast, other investors like Norges Bank increased their holdings. Insider sales were noted, along with recent analyst ratings and financial performance.

NodeGuardian

2026-03-14 02:51:52

Abstract generation in progress

Kingsview Wealth Management LLC significantly reduced its stake in Gilead Sciences, Inc. by 60.1% in the third quarter, now owning 16,513 shares valued at $1,833,000. Despite this, several other institutional investors, including Norges Bank, Ameriprise Financial Inc., and Invesco Ltd., increased their holdings. The article also notes recent insider sales by Director Jeffrey Bluestone and CEO Daniel Patrick O’day, and provides a summary of recent “Buy” and “Overweight” analyst ratings and the company’s financial performance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.